Calendario de promoción Cocrystal Pharma, Inc.
Horario avanzado
gráfico sencillo
Acerca de la empresa Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. más detalles| IPO date | 2011-05-19 |
|---|---|
| ISIN | US19188J3005 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.cocrystalpharma.com |
| Цена ао | 1.5 |
| Cambio de precio por día: | +3.5% (1.43) |
|---|---|
| Cambio de precio por semana.: | -5.13% (1.56) |
| Cambio de precio por mes: | -14.94% (1.74) |
| Cambio de precio en 3 meses.: | -52.1% (3.09) |
| Cambio de precio en seis meses: | -15.91% (1.76) |
| Cambio de precio por año: | +5.71% (1.4) |
| Cambio de precio en 3 años.: | +150.85% (0.59) |
| Cambio de precio en 5 años.: | +8.03% (1.37) |
| Cambio de precio desde principios de año.: | -26.73% (2.02) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| Vanguard Group Inc | 275656 | 2.71 |
| Renaissance Technologies, LLC | 125128 | 1.23 |
| Blackrock Inc. | 74063 | 0.73 |
| Geode Capital Management, LLC | 60432 | 0.59 |
| Morgan Stanley | 59277 | 0.58 |
| Susquehanna International Group, LLP | 34544 | 0.34 |
| State Street Corporation | 24443 | 0.24 |
| Northern Trust Corporation | 12207 | 0.12 |
| Bank of America Corporation | 8979 | 0.09 |
| Tower Research Capital LLC (TRC) | 5844 | 0.06 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Dr. Sam Lee Ph.D. | Co-Founder, Co-CEO & President | 559.82k | 1960 (65 años) |
| Prof. Roger D. Kornberg Ph.D. | Co-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board | 1947 (78 años) | |
| Mr. James J. Martin CPA, M.B.A. | Co-CEO, CFO & Corporate Secretary | 1967 (58 años) |
DIRECCIÓN: United States, Bothell. WA, 19805 North Creek Parkway - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.cocrystalpharma.com
Sitio web: https://www.cocrystalpharma.com
